Medpace Holdings Total Long Term Liabilities 2014-2024 | MEDP

Medpace Holdings total long term liabilities from 2014 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Medpace Holdings total long term liabilities for the quarter ending September 30, 2024 were $0.161B, a 3.6% decline year-over-year.
  • Medpace Holdings total long term liabilities for 2023 were $0.173B, a 6.22% increase from 2022.
  • Medpace Holdings total long term liabilities for 2022 were $0.163B, a 8.58% increase from 2021.
  • Medpace Holdings total long term liabilities for 2021 were $0.15B, a 3.45% increase from 2020.
Medpace Holdings Annual Total Long Term Liabilities
(Millions of US $)
2023 $173
2022 $163
2021 $150
2020 $145
2019 $74
2018 $121
2017 $254
2016 $200
2015 $437
2014 $561
2013 $
Medpace Holdings Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $161
2024-06-30 $163
2024-03-31 $168
2023-12-31 $173
2023-09-30 $167
2023-06-30 $163
2023-03-31 $167
2022-12-31 $163
2022-09-30 $158
2022-06-30 $153
2022-03-31 $160
2021-12-31 $150
2021-09-30 $162
2021-06-30 $145
2021-03-31 $145
2020-12-31 $145
2020-09-30 $146
2020-06-30 $146
2020-03-31 $81
2019-12-31 $74
2019-09-30 $66
2019-06-30 $63
2019-03-31 $120
2018-12-31 $121
2018-09-30 $156
2018-06-30 $195
2018-03-31 $229
2017-12-31 $254
2017-09-30 $226
2017-06-30 $201
2017-03-31 $195
2016-12-31 $200
2016-09-30 $209
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2014-12-31 $561
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00